EA199801045A1 - Комбинации, содержащие vx478, зидовудин, ftc и/или 3тс, для применения при лечении вич - Google Patents
Комбинации, содержащие vx478, зидовудин, ftc и/или 3тс, для применения при лечении вичInfo
- Publication number
- EA199801045A1 EA199801045A1 EA199801045A EA199801045A EA199801045A1 EA 199801045 A1 EA199801045 A1 EA 199801045A1 EA 199801045 A EA199801045 A EA 199801045A EA 199801045 A EA199801045 A EA 199801045A EA 199801045 A1 EA199801045 A1 EA 199801045A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- amino
- ftc
- hiv
- treating hiv
- zidovudin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Abstract
Настоящее изобретение относится к терапевтическим комбинациям тетрагидро-3-фуранилового эфира 3S-[3R*(1R*, 2S*)-[3-[[(4-аминофенил)сульфонил](2-метилпропил)-амино]-2-гидрокси-1-фенил-метил)пропил] карбаминовой кислоты (141W94), 3'-азидо-3'-дезокситимидина (зидовудина) и (2R, цис)-4-амино-1-(2-гидроксиметил-1,3-оксатиолан-5-ил)-(1Н)-пиримидин-2-она (3ТС) (или, альтернативно 3ТС, (2R, цис)-4-амино-5-фтор-1-(2-гидроксиметил)-1,3-оксатиолан-5-ил)-(1Н)-пиримидин-2-она (FTC)), которые обладают анти-ВИЧ активностью. Настоящее изобретение также относится к фармацевтическим композициям, содержащим указанные комбинации, и к их применению при лечении ВИЧ инфекций, включая инфекции ВИЧ мутантов, несущих резистентность к нуклеозидным и/или ненуклеозидным ингибиторам.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2054396P | 1996-06-25 | 1996-06-25 | |
US2102796P | 1996-07-02 | 1996-07-02 | |
GBGB9614022.3A GB9614022D0 (en) | 1996-07-04 | 1996-07-04 | Antiviral therapeutic combinations |
PCT/EP1997/003247 WO1997049411A1 (en) | 1996-06-25 | 1997-06-23 | Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv |
Publications (2)
Publication Number | Publication Date |
---|---|
EA199801045A1 true EA199801045A1 (ru) | 1999-08-26 |
EA001517B1 EA001517B1 (ru) | 2001-04-23 |
Family
ID=27268358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA199801045A EA001517B1 (ru) | 1996-06-25 | 1997-06-23 | Комбинации, содержащие vx478, зидовудин и 3tc, для применения при лечении вич |
Country Status (26)
Country | Link |
---|---|
US (1) | US6544961B1 (ru) |
EP (1) | EP0938321B1 (ru) |
JP (1) | JP2000515852A (ru) |
KR (1) | KR20000022226A (ru) |
CN (1) | CN1228026A (ru) |
AP (1) | AP9801419A0 (ru) |
AT (1) | ATE257708T1 (ru) |
AU (1) | AU727983B2 (ru) |
BR (1) | BR9709939A (ru) |
CA (1) | CA2258956A1 (ru) |
CO (1) | CO4900074A1 (ru) |
CZ (1) | CZ429498A3 (ru) |
DE (1) | DE69727240T2 (ru) |
EA (1) | EA001517B1 (ru) |
ES (1) | ES2213217T3 (ru) |
HU (1) | HUP9903249A3 (ru) |
ID (1) | ID19490A (ru) |
IL (1) | IL127351A0 (ru) |
IS (1) | IS4915A (ru) |
NO (1) | NO986034L (ru) |
NZ (1) | NZ333099A (ru) |
PL (1) | PL330747A1 (ru) |
TR (1) | TR199802704T2 (ru) |
TW (1) | TW469132B (ru) |
WO (1) | WO1997049411A1 (ru) |
YU (1) | YU58398A (ru) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY115461A (en) | 1995-03-30 | 2003-06-30 | Wellcome Found | Synergistic combinations of zidovudine, 1592u89 and 3tc |
US6875773B1 (en) | 1998-05-29 | 2005-04-05 | Ben M. Dunn | Combination therapy for treatment of FIV infection |
AU4219799A (en) * | 1998-05-29 | 1999-12-13 | University Of Florida | Combination therapy for treatment of fiv infection |
GB0011903D0 (en) * | 2000-05-18 | 2000-07-05 | Astrazeneca Ab | Combination chemotherapy |
NZ554779A (en) * | 2005-02-01 | 2011-02-25 | Troikaa Pharmaceuticals Ltd | Injectable preparations of diclofenac ((2,6-dichloranilino)phenylacetic acid) and its pharmaceutically acceptable salts |
ES2279707B1 (es) * | 2005-11-10 | 2008-06-01 | Combino Pharm, S.L. | Formulaciones orales que comprenden 3'-azidonucleosidos. |
US8168662B1 (en) | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US8168661B2 (en) * | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US8178564B2 (en) * | 2006-11-06 | 2012-05-15 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US8173686B2 (en) | 2006-11-06 | 2012-05-08 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US20110033528A1 (en) * | 2009-08-05 | 2011-02-10 | Poniard Pharmaceuticals, Inc. | Stabilized picoplatin oral dosage form |
US20100260832A1 (en) * | 2007-06-27 | 2010-10-14 | Poniard Pharmaceuticals, Inc. | Combination therapy for ovarian cancer |
TW200916094A (en) * | 2007-06-27 | 2009-04-16 | Poniard Pharmaceuticals Inc | Stabilized picoplatin dosage form |
WO2009011861A1 (en) * | 2007-07-16 | 2009-01-22 | Poniard Pharmaceuticals, Inc. | Oral formulations for picoplatin |
US20110052580A1 (en) * | 2008-02-08 | 2011-03-03 | Poniard Pharmaceuticals, Inc. | Use of picoplatin and bevacizumab to treat colorectal cancer |
MX367937B (es) * | 2010-01-27 | 2019-09-12 | Viiv Healthcare Co | Combinaciones de compuestos que comprenden inhibidores de la integrasa de vih y otros agentes terapéuticos. |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4724232A (en) * | 1985-03-16 | 1988-02-09 | Burroughs Wellcome Co. | Treatment of human viral infections |
US5047407A (en) | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
MY104575A (en) * | 1989-12-22 | 1994-04-30 | The Wellcome Foundation Ltd | Therapeutic nucleosides. |
US5204466A (en) | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
GB9009861D0 (en) | 1990-05-02 | 1990-06-27 | Glaxo Group Ltd | Chemical compounds |
IL100502A (en) | 1991-01-03 | 1995-12-08 | Iaf Biochem Int | PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (- |
IL100965A (en) * | 1991-02-22 | 1999-12-31 | Univ Emory | 2 - Hydroxymethyl - 5 -) 5 - Fluorocytocin - 1 - Eyal (- 1, 3 - Oxathiolane, its resolution and pharmaceuticals containing it |
GB9104740D0 (en) * | 1991-03-06 | 1991-04-17 | Wellcome Found | Antiviral nucleoside combination |
SK279262B6 (sk) | 1991-05-16 | 1998-08-05 | Glaxo Group Limited | Protivírusová zmes, farmaceutický prostriedok s je |
GB9111902D0 (en) | 1991-06-03 | 1991-07-24 | Glaxo Group Ltd | Chemical compounds |
GB9307013D0 (en) * | 1993-04-02 | 1993-05-26 | Wellcome Found | Therapeutic combinations |
DK0656887T3 (da) | 1992-08-25 | 1999-07-05 | Searle & Co | Hydroxyethylaminosulfonamider til anvendelse som inhibitorer af retrovirale proteaser |
IS2334B (is) * | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl próteasi hemjari af nýjum flokki súlfonamíða |
US5723490A (en) * | 1992-09-08 | 1998-03-03 | Vertex Pharmaceuticals Incorporated | THF-containing sulfonamide inhibitors of aspartyl protease |
UA49803C2 (ru) * | 1994-06-03 | 2002-10-15 | Дж.Д. Сьорль Енд Ко | Способ лечения ретровирусных инфекций |
GB9503850D0 (en) | 1995-02-25 | 1995-04-19 | Glaxo Group Ltd | Medicaments |
US5869461A (en) | 1995-03-16 | 1999-02-09 | Yale University | Reducing toxicity of L-nucleosides with D-nucleosides |
MY115461A (en) * | 1995-03-30 | 2003-06-30 | Wellcome Found | Synergistic combinations of zidovudine, 1592u89 and 3tc |
US5646180A (en) * | 1995-12-05 | 1997-07-08 | Vertex Pharmaceuticals Incorporated | Treatment of the CNS effects of HIV |
TW536403B (en) | 1997-03-24 | 2003-06-11 | Glaxo Group Ltd | An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy |
-
1997
- 1997-06-23 BR BR9709939A patent/BR9709939A/pt unknown
- 1997-06-23 NZ NZ333099A patent/NZ333099A/en unknown
- 1997-06-23 US US09/202,660 patent/US6544961B1/en not_active Expired - Fee Related
- 1997-06-23 ES ES97928263T patent/ES2213217T3/es not_active Expired - Lifetime
- 1997-06-23 CA CA002258956A patent/CA2258956A1/en not_active Abandoned
- 1997-06-23 EA EA199801045A patent/EA001517B1/ru not_active IP Right Cessation
- 1997-06-23 KR KR1019980710646A patent/KR20000022226A/ko not_active Application Discontinuation
- 1997-06-23 AU AU32627/97A patent/AU727983B2/en not_active Ceased
- 1997-06-23 CO CO97034781A patent/CO4900074A1/es unknown
- 1997-06-23 TR TR1998/02704T patent/TR199802704T2/xx unknown
- 1997-06-23 PL PL97330747A patent/PL330747A1/xx unknown
- 1997-06-23 EP EP97928263A patent/EP0938321B1/en not_active Expired - Lifetime
- 1997-06-23 JP JP10502320A patent/JP2000515852A/ja not_active Ceased
- 1997-06-23 WO PCT/EP1997/003247 patent/WO1997049411A1/en active Search and Examination
- 1997-06-23 HU HU9903249A patent/HUP9903249A3/hu unknown
- 1997-06-23 AP APAP/P/1998/001419A patent/AP9801419A0/en unknown
- 1997-06-23 ID IDP972147A patent/ID19490A/id unknown
- 1997-06-23 AT AT97928263T patent/ATE257708T1/de not_active IP Right Cessation
- 1997-06-23 DE DE69727240T patent/DE69727240T2/de not_active Expired - Fee Related
- 1997-06-23 CN CN97197357A patent/CN1228026A/zh active Pending
- 1997-06-23 IL IL12735197A patent/IL127351A0/xx unknown
- 1997-06-23 CZ CZ984294A patent/CZ429498A3/cs unknown
- 1997-08-05 TW TW086111193A patent/TW469132B/zh active
-
1998
- 1998-11-30 IS IS4915A patent/IS4915A/is unknown
- 1998-12-16 YU YU58398A patent/YU58398A/sr unknown
- 1998-12-22 NO NO986034A patent/NO986034L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP9903249A3 (en) | 2001-04-28 |
ES2213217T3 (es) | 2004-08-16 |
CA2258956A1 (en) | 1997-12-31 |
US6544961B1 (en) | 2003-04-08 |
ID19490A (id) | 1998-07-16 |
DE69727240T2 (de) | 2004-11-25 |
AU727983B2 (en) | 2001-01-04 |
KR20000022226A (ko) | 2000-04-25 |
CO4900074A1 (es) | 2000-03-27 |
ATE257708T1 (de) | 2004-01-15 |
EA001517B1 (ru) | 2001-04-23 |
BR9709939A (pt) | 1999-08-10 |
NO986034D0 (no) | 1998-12-22 |
YU58398A (en) | 1999-11-22 |
WO1997049411A1 (en) | 1997-12-31 |
NZ333099A (en) | 2000-06-23 |
AP9801419A0 (en) | 1998-12-31 |
CZ429498A3 (cs) | 1999-06-16 |
EP0938321A1 (en) | 1999-09-01 |
NO986034L (no) | 1999-02-23 |
IS4915A (is) | 1998-11-30 |
AU3262797A (en) | 1998-01-14 |
JP2000515852A (ja) | 2000-11-28 |
TW469132B (en) | 2001-12-21 |
EP0938321B1 (en) | 2004-01-14 |
HUP9903249A2 (hu) | 2000-10-28 |
IL127351A0 (en) | 1999-10-28 |
TR199802704T2 (xx) | 1999-03-22 |
PL330747A1 (en) | 1999-05-24 |
CN1228026A (zh) | 1999-09-08 |
DE69727240D1 (de) | 2004-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA199700203A1 (ru) | Синергические комбинации зидовудина, 1592u89 и 3тс или ftc | |
EA199801045A1 (ru) | Комбинации, содержащие vx478, зидовудин, ftc и/или 3тс, для применения при лечении вич | |
NO20053817L (no) | Preparater og fremgangsmater for antiviral kombinasjonsterapi. | |
ES2377066T3 (es) | Composición terapéutica que contiene al menos un derivado de la pirrobenzodiacepina y la fludarabina | |
TNSN92070A1 (fr) | Les analogues du necleoside de 13-oxathiolane | |
EA200100053A1 (ru) | Кальций (3s)тетрагидро-3-фуранил(1s,2r)-3-[[(4-аминофенил)сульфонил](изобутил)амино]-1-бензил-2-(фосфоноокси)пропилкарбамат | |
DE60237696D1 (de) | Am n-terminus trunkierte isoformen von zyklischen phosphodiesterasen pde3a | |
UA41265C2 (uk) | Кристалічна форма (-)-цис-4-аміно-1-(2-гідроксиметил-1,3-оксатіолан-5-іл)-(1н)-піримідин-2-ону (варіанти), способи її отримання та фармацевтична композиція | |
ES2095960T3 (es) | Compuestos que tienen propiedades antihipertensivas y antiisquemicas. | |
CO2022018715A2 (es) | Análogos de nucleósido de 1’-ciano y usos de los mismos | |
EA200500300A1 (ru) | Цитотоксические агенты, содержащие новые сильнодействующие таксаны, и их терапевтическое применение | |
BR9507846A (pt) | Composição farmacéutica estável e fortemente concentrada de principio ativo da classe dos taxóides escolhido entre o docetaxol ou os derivados do docetaxol processo de preparação desta composição e utilização de uma solução congelada ou liofilizada | |
EA199900757A1 (ru) | Фармацевтические композиции | |
EA199801046A1 (ru) | Комбинации, содержащие vx478, зидовудин и/или 1592u89, для применения при лечении вич | |
AR023661A1 (es) | Combinaciones antivirales | |
WO2001030329A3 (en) | Combinations of lamivudine and entecavir for treatment of hepatitis b virus infuction | |
AR007616A1 (es) | Combinaciones antivirales | |
AR043332A1 (es) | Composiciones y metodos para terapia antiviral | |
TH34798A (th) | การรวมสารต้านไวรัส | |
AR040805A1 (es) | Composiciones que contienen tenofovir y emtricitabina y metodos para terapia antiviral | |
WO2000018384A3 (en) | Antiviral combinations comprising (s)-2-ethyl-7-fluoro-3-oxo-3,4-dihydro-2h-quinoxaline-1-carboxylic acid isopropyl ester and amprenavir | |
FR2863496A1 (fr) | Composition therapeutique destinee au traitement des troubles de l'accomodation de l'oeil humain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |